A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis

Empagliflozin-induced euglycemic diabetic ketoacidosis is a life-threatening metabolic complication of diabetes mellitus characterized by metabolic acidosis, ketonemia, and relatively normal serum glucose levels. We present a rare case of empagliflozin-induced diabetic ketoacidosis obscured by alkal...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez Felix, Daniel A, Madrigal Loria, Gloriana, Sharma, Sapna, Sharma, Shorabh, Arias Morales, Carlos E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186101/
https://www.ncbi.nlm.nih.gov/pubmed/35698468
http://dx.doi.org/10.7759/cureus.25818
_version_ 1784724861653876736
author Fernandez Felix, Daniel A
Madrigal Loria, Gloriana
Sharma, Sapna
Sharma, Shorabh
Arias Morales, Carlos E
author_facet Fernandez Felix, Daniel A
Madrigal Loria, Gloriana
Sharma, Sapna
Sharma, Shorabh
Arias Morales, Carlos E
author_sort Fernandez Felix, Daniel A
collection PubMed
description Empagliflozin-induced euglycemic diabetic ketoacidosis is a life-threatening metabolic complication of diabetes mellitus characterized by metabolic acidosis, ketonemia, and relatively normal serum glucose levels. We present a rare case of empagliflozin-induced diabetic ketoacidosis obscured by alkalosis. This case report aims to create awareness among clinicians about this entity and consider this diagnosis in their differential, especially in patients taking sodium-glucose co-transporter (SGLT-2) inhibitors who present to the hospital with unspecific symptoms that may not suggest DKA.
format Online
Article
Text
id pubmed-9186101
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-91861012022-06-12 A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis Fernandez Felix, Daniel A Madrigal Loria, Gloriana Sharma, Sapna Sharma, Shorabh Arias Morales, Carlos E Cureus Endocrinology/Diabetes/Metabolism Empagliflozin-induced euglycemic diabetic ketoacidosis is a life-threatening metabolic complication of diabetes mellitus characterized by metabolic acidosis, ketonemia, and relatively normal serum glucose levels. We present a rare case of empagliflozin-induced diabetic ketoacidosis obscured by alkalosis. This case report aims to create awareness among clinicians about this entity and consider this diagnosis in their differential, especially in patients taking sodium-glucose co-transporter (SGLT-2) inhibitors who present to the hospital with unspecific symptoms that may not suggest DKA. Cureus 2022-06-10 /pmc/articles/PMC9186101/ /pubmed/35698468 http://dx.doi.org/10.7759/cureus.25818 Text en Copyright © 2022, Fernandez Felix et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Fernandez Felix, Daniel A
Madrigal Loria, Gloriana
Sharma, Sapna
Sharma, Shorabh
Arias Morales, Carlos E
A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis
title A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis
title_full A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis
title_fullStr A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis
title_full_unstemmed A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis
title_short A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis
title_sort rare case of empagliflozin-induced euglycemic diabetic ketoacidosis obscured by alkalosis
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186101/
https://www.ncbi.nlm.nih.gov/pubmed/35698468
http://dx.doi.org/10.7759/cureus.25818
work_keys_str_mv AT fernandezfelixdaniela ararecaseofempagliflozininducedeuglycemicdiabeticketoacidosisobscuredbyalkalosis
AT madrigalloriagloriana ararecaseofempagliflozininducedeuglycemicdiabeticketoacidosisobscuredbyalkalosis
AT sharmasapna ararecaseofempagliflozininducedeuglycemicdiabeticketoacidosisobscuredbyalkalosis
AT sharmashorabh ararecaseofempagliflozininducedeuglycemicdiabeticketoacidosisobscuredbyalkalosis
AT ariasmoralescarlose ararecaseofempagliflozininducedeuglycemicdiabeticketoacidosisobscuredbyalkalosis
AT fernandezfelixdaniela rarecaseofempagliflozininducedeuglycemicdiabeticketoacidosisobscuredbyalkalosis
AT madrigalloriagloriana rarecaseofempagliflozininducedeuglycemicdiabeticketoacidosisobscuredbyalkalosis
AT sharmasapna rarecaseofempagliflozininducedeuglycemicdiabeticketoacidosisobscuredbyalkalosis
AT sharmashorabh rarecaseofempagliflozininducedeuglycemicdiabeticketoacidosisobscuredbyalkalosis
AT ariasmoralescarlose rarecaseofempagliflozininducedeuglycemicdiabeticketoacidosisobscuredbyalkalosis

Ejemplares similares